Search results for "Highlights"
Highlights
Long-term results from the Longitudinal Assessment of Bariatric Surgery suggested that diabetes remission is more likely after bariatric surgery performed soon after diagnosis, when diabetes medication burden is low and beta-cell function is
December 2020
Highlights
Risk of Alzheimer's disease or vascular dementia was not associated with nonfasting plasma glucose levels in a large Danish study that included patients with and without diabetes.
April 2020
Highlights
The guideline includes recommendations on the use of statins and lipid testing in type 1 and 2 diabetes, as well as other endocrine-related diseases and conditions.
November 2020
Highlights
Patients with diabetes and mild-to-moderate cardiomyopathy had higher mortality risk than nondiabetic patients with severe cardiomyopathy, suggesting that they may benefit from implantable cardioverter defibrillators, according to the study authors.
March 2020
Highlights
While both procedures were associated with high rates of type 2 diabetes remission, the rate of remission five years after surgery was about 10% higher in patients who had gastric bypass than in those who had sleeve gastrectomy.
March 2020
Highlights
The authors of a systematic review and meta-analysis recommended reconsideration of guidelines on sodium-glucose cotransporter-2 (SGLT-2) inhibitors to increase use among patients at risk of cardiovascular disease.
February 2020
Highlights
About one-third of men approached in barbershops owned by black individuals were willing to be screened for diabetes, and 9% of them had undiagnosed diabetes while 28% had prediabetes.
February 2020
Keeping tabs
While weight loss and improved fitness should both be recommended for patients with diabetes, these observational results highlight the need for further research to test whether prevention strategies focusing on improving
February 2020
Highlights
An accompanying editorial noted that the results from this Chinese study highlight the need for a global emphasis on preventing cardiovascular disease.
August 2019
Highlights
The results highlight the heterogeneity of type 2 diabetes and may help explain the differences in disease progression and response to glucose-lowering treatment seen in clinical practice, an accompanying comment
August 2019